TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma | |
Zhang, Xin; Wan, Jin-Xiang; Ke, Zun-Ping; Wang, Feng; Chai, Hai-Xia; Liu, Jia-Qiang | |
刊名 | TUMOR BIOLOGY |
2017 | |
卷号 | 39期号:7 |
关键词 | Hepatocellular carcinoma The Cancer Genome Atlas Kaplan-Meier survival analysis cluster analysis driver genes |
ISSN号 | 1010-4283 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3614654 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Zhang, Xin,Wan, Jin-Xiang,Ke, Zun-Ping,et al. TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma[J]. TUMOR BIOLOGY,2017,39(7). |
APA | Zhang, Xin,Wan, Jin-Xiang,Ke, Zun-Ping,Wang, Feng,Chai, Hai-Xia,&Liu, Jia-Qiang.(2017).TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma.TUMOR BIOLOGY,39(7). |
MLA | Zhang, Xin,et al."TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma".TUMOR BIOLOGY 39.7(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论